Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Getz

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2020
Effect of Dexrazoxane on Left Ventricular Systolic Function and Treatment Outcomes in Patients With Acute Myeloid Leukemia: A Report From the Children's Oncology GroupKelly D Getz, Lillian Sung, Todd A Alonzo, et al.
Pediatric Blood & Cancer|March 11, 2021
Presentation acuity, induction mortality, and resource utilization in infants with acute leukemiaAzada Ibrahimova, Lena E Winestone, Tamara P Miller, et al.
Cancer Medicine|July 31, 2016
Early discharge as a mediator of greater ICU-level care requirements in patients not enrolled on the AAML0531 clinical trial: a Children's Oncology Group reportKelly D Getz, Tamara P Miller, Alix E Seif, et al.
Pediatric Blood & Cancer|December 30, 2017
Identifying patient- and family-centered outcomes relevant to inpatient versus at-home management of neutropenia in children with acute myeloid leukemiaJulia E Szymczak, Kelly D Getz, Rachel Madding, et al.
Neuro-Oncology|January 12, 2022
Risk factors for treatment-refractory and relapsed optic pathway glioma in children with neurofibromatosis type 1Chelsea Kotch, Robert Avery, Kelly D Getz, et al.
Haematologica|January 27, 2022
A report from the Leukemia Electronic Abstraction of Records Network on risk of hepatotoxicity during pediatric acute lymphoblastic leukemia treatmentJoanna S Yi, Tiffany M Chambers, Kelly D Getz, et al.
Pediatric Blood & Cancer|November 23, 2021
Incidence and risk factors for hypoglycemia during maintenance chemotherapy in pediatric acute lymphoblastic leukemiaElizabeth Rosenfeld, Kelly D Getz, Tamara P Miller, et al.
Journal of the National Cancer Institute|November 23, 2020
Poverty and Targeted Immunotherapy: Survival in Children's Oncology Group Clinical Trials for High-Risk NeuroblastomaKira Bona, Yimei Li, Lena E Winestone, et al.
American Journal of Hematology|November 19, 2016
The role of acuity of illness at presentation in early mortality in black children with acute myeloid leukemiaLena E Winestone, Kelly D Getz, Tamara P Miller, et al.
Pediatric Blood & Cancer|September 2, 2021
Cytarabine dose reduction in patients with low-risk acute myeloid leukemia: A report from the Children's Oncology GroupKelly D Getz, Todd A Alonzo, Lillian Sung, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2020
Effect of Dexrazoxane on Left Ventricular Systolic Function and Treatment Outcomes in Patients With Acute Myeloid Leukemia: A Report From the Children's Oncology GroupKelly D Getz, Lillian Sung, Todd A Alonzo, et al.
Pediatric Blood & Cancer|March 11, 2021
Presentation acuity, induction mortality, and resource utilization in infants with acute leukemiaAzada Ibrahimova, Lena E Winestone, Tamara P Miller, et al.
Cancer Medicine|July 31, 2016
Early discharge as a mediator of greater ICU-level care requirements in patients not enrolled on the AAML0531 clinical trial: a Children's Oncology Group reportKelly D Getz, Tamara P Miller, Alix E Seif, et al.
Pediatric Blood & Cancer|December 30, 2017
Identifying patient- and family-centered outcomes relevant to inpatient versus at-home management of neutropenia in children with acute myeloid leukemiaJulia E Szymczak, Kelly D Getz, Rachel Madding, et al.
Neuro-Oncology|January 12, 2022
Risk factors for treatment-refractory and relapsed optic pathway glioma in children with neurofibromatosis type 1Chelsea Kotch, Robert Avery, Kelly D Getz, et al.
Haematologica|January 27, 2022
A report from the Leukemia Electronic Abstraction of Records Network on risk of hepatotoxicity during pediatric acute lymphoblastic leukemia treatmentJoanna S Yi, Tiffany M Chambers, Kelly D Getz, et al.
Pediatric Blood & Cancer|November 23, 2021
Incidence and risk factors for hypoglycemia during maintenance chemotherapy in pediatric acute lymphoblastic leukemiaElizabeth Rosenfeld, Kelly D Getz, Tamara P Miller, et al.
Journal of the National Cancer Institute|November 23, 2020
Poverty and Targeted Immunotherapy: Survival in Children's Oncology Group Clinical Trials for High-Risk NeuroblastomaKira Bona, Yimei Li, Lena E Winestone, et al.
American Journal of Hematology|November 19, 2016
The role of acuity of illness at presentation in early mortality in black children with acute myeloid leukemiaLena E Winestone, Kelly D Getz, Tamara P Miller, et al.
Pediatric Blood & Cancer|September 2, 2021
Cytarabine dose reduction in patients with low-risk acute myeloid leukemia: A report from the Children's Oncology GroupKelly D Getz, Todd A Alonzo, Lillian Sung, et al.
Pageof 10